Approaches for immunotherapy of lymphomas.
Kwak
L W
LW
National Cancer Institute, Division of Clinical Sciences, Bethesda, MD, USA.
D000912:Antibodies, Neoplasm / Q000096:biosynthesis; D000951:Antigens, Neoplasm; D001402:B-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007130:Immunoglobulin Idiotypes; D016233:Immunotherapy, Active / Q000379:methods*; D008223:Lymphoma / Q000276:immunology / Q000628:therapy*; D008224:Lymphoma, Follicular / Q000276:immunology / Q000628:therapy
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D007130:Immunoglobulin Idiotypes